Full-service CDMO KP Pharmaceutical Technology operates as a single-source partner from formulation development to commercial scale, presenting a clear upsell path for biotech clients seeking streamlined development-to-manufacturing integration.

Sterile and non-sterile With capabilities in sterile injectables and non-sterile dosage forms under one roof, there is a cross-sell opportunity to biotech programs requiring end-to-end production for multiple product formats.

FDA registered Capitalizing on FDA-registered, inspection-ready facilities in Bloomington signals quality and compliance credibility, making KP a strong candidate for clients needing compliant scale-up and portfolio diversification.

Emerging biotech focus Target emerging biotech companies seeking agile, responsive development partners; highlight KP’s nearly three decades of cGMP experience and personalized service as a differentiator against larger CROs.

Mid-market capacity With revenue in the lower/mid million range and small employee footprint, there is an opportunity to expand value propositions through larger-scale manufacturing projects, capacity expansions, and strategic partnerships as clients scale.